Good point. I think you would probably only consider the direct costs to those donors (pain/morbidity/risk) and not foregone donations, since presumably the typical liver donor participating in a chain is not devoting a lot of their earnings to impactful charity.
Good point. I think you would probably only consider the direct costs to those donors (pain/morbidity/risk) and not foregone donations, since presumably the typical liver donor participating in a chain is not devoting a lot of their earnings to impactful charity.